Business Context and Reporting Period
Senseonics Holdings, Inc. (SENS) filed a Form 8-K on January 12, 2026, to report preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The filing includes business updates and operational metrics alongside the financial data.
Key Financial Metrics
- Revenue (Q4 2025): Approximately $14.2 million (preliminary, unaudited).
- Revenue (Full Year 2025): Approximately $35.2 million (preliminary, unaudited).
- Cash Position: Cash, cash equivalents, and restricted cash as of December 31, 2025, are expected to be approximately $94.3 million.
- Profit, Margins, and Debt: The filing text does not provide clear values for net income, profit margins, or debt levels.
Material Changes and Operational Highlights
- Patient Base Growth: The company reported a 103% increase in its patient base in the fourth quarter of 2025 compared to the fourth quarter of 2024.
- Revenue Trend: The full-year revenue of $35.2 million implies significant growth, though the filing does not explicitly state the year-over-year percentage change for the full year.
Guidance, Risks, and Unusual Items
The financial information presented is preliminary and unaudited. Management notes that actual audited results may differ materially due to uncertainties in the financial close process and the upcoming audit. The filing includes standard forward-looking statement disclaimers regarding future expectations, plans, and prospects. No specific guidance for 2026 was provided in this text, nor were specific unusual items or contingencies detailed beyond the standard audit risk factors.
Investor Verification Checklist
- Verify the final audited revenue figures for Q4 and full-year 2025 once the 10-K is filed.
- Confirm the final cash balance and any changes in restricted cash upon audit completion.
- Review the upcoming 10-K for detailed profit/loss statements, operating margins, and debt covenants not included in this 8-K.
- Assess the sustainability of the 103% patient base growth rate in subsequent quarters.